Amgen Inc. logo

Amgen Inc. (AMGN)

Market Closed
4 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
340. 16
-5.26
-1.52%
$
185.54B Market Cap
19.61 P/E Ratio
9% Div Yield
3,441,746 Volume
18.58 Eps
$ 345.42
Previous Close
Day Range
338.94 346.3
Year Range
253.3 346.38
Want to track AMGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 month ago
Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 1 month ago
Amgen's Q3 Earnings in the Cards: Here's What to Expect

Amgen's Q3 Earnings in the Cards: Here's What to Expect

Amgen's Q3 results are on deck, with growth from newer drugs offset by biosimilar competition and pricing pressures.

Zacks | 1 month ago
Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline

Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 month ago
Amgen (AMGN) Laps the Stock Market: Here's Why

Amgen (AMGN) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Amgen (AMGN) stood at $297.32, denoting a +1.18% move from the preceding trading day.

Zacks | 1 month ago
Why Amgen (AMGN) Could Beat Earnings Estimates Again

Why Amgen (AMGN) Could Beat Earnings Estimates Again

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 month ago
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen (AMGN) reached $294.12 at the closing of the latest trading day, reflecting a -1.27% change compared to its last close.

Zacks | 1 month ago
Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

The biotechnology company said that it has launched AmgenNow, a new direct-to-patient program, starting with its drug Repatha.

Wsj | 1 month ago
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
Amgen Shares Cross Above 200 DMA

Amgen Shares Cross Above 200 DMA

In trading on Wednesday, shares of Amgen crossed above their 200 day moving average of $287.75, changing hands as high as $296.76 per share. Amgen shares are currently trading up about 5% on the day.

Forbes | 2 months ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks | 2 months ago
Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
Loading...
Load More